Subscribe to Newsletter

Search

Reset Filter
You have a filtered search result

137 search results for ‘*’

Business & Regulation Standards & Regulation

Lobby and Legislature Play Pricing Plan Ping Pong

| Angus Stewart

After a madcap back and forth between leading and dissenting Democrats, Biden’s drug pricing reform plans have reached a compromised final form.

Manufacture Contract Manufacturing Services

One Stop Shop

| Adam Stops

In a market filled with complexity, working with a single supplier simplifies the supply chain and focuses effort towards a single target.

Discovery & Development Ingredients

Natural Born Therapeutics

| Angus Stewart

Researchers at Trinity College Dublin explain how they are reaching into the natural environment to source new bioactives.

Manufacture Contract Manufacturing Services

Weathering the Storm Together - Part 1

| Stephanie Vine

The efforts of CDMOs have been absolutely crucial in the pandemic response. We ask five CDMO gurus how they reacted to COVID-19.

Manufacture Contract Manufacturing Services

Weathering the Storm Together - Part 2

| Stephanie Vine

Part 2 of our roundtable discussion with CDMOs covers outsourcing preferences, the demand for mRNA, and more.

Manufacture Facilities

Giving It All We’ve Got: Lessons Learned from Operation Warp Speed

| Jarrod Wrampe, Charles Heffernan

What lessons were learned from Operation Warp Speed?

Business & Regulation Business Practice

Stepping Away from the Flame

| Maryam Mahdi

The pharma industry is one of the biggest targets for cybercrime. How can companies avoid succumbing to attack?

Manufacture Contract Manufacturing Services

Tackling the High-Potency Trend

| Sponsored by PCI

Defining the best strategies for working with highly potent drug substances.

Manufacture Advanced Medicine

mRNA: Reaching for the Sun

| Maryam Mahdi

What milestones will define the next era in the mRNA story?

Manufacture Bioprocessing - Upstream & Downstream

The Rise of mRNA: New Era, New Challenges

| Amélie Boulais, Jay Zhang, Nitin Chopra

Manufacturers must look to ease the headaches associated with the manufacture of mRNA-based products.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register